Literature DB >> 31659864

Structural conformation and self-assembly process of p31-43 gliadin peptide in aqueous solution. Implications for celiac disease.

María Georgina Herrera1, María Florencia Gómez Castro2, Eduardo Prieto3, Exequiel Barrera4, Veronica Isabel Dodero5, Sergio Pantano4,6, Fernando Chirdo2.   

Abstract

Celiac disease (CeD) is a highly prevalent chronic immune-mediated enteropathy developed in genetically predisposed individuals after ingestion of a group of wheat proteins (called gliadins and glutenins). The 13mer α-gliadin peptide, p31-43, induces proinflammatory responses, observed by in vitro assays and animal models, that may contribute to innate immune mechanisms of CeD pathogenesis. Since a cellular receptor for p31-43 has not been identified, this raises the question of whether this peptide could mediate different biological effects. In this work, we aimed to characterize the p31-43 secondary structure by different biophysical and in silico techniques. By dynamic light scattering and using an oligomer/fibril-sensitive fluorescent probe, we showed the presence of oligomers of this peptide in solution. Furthermore, atomic force microscopy analysis showed p31-43 oligomers with different height distribution. Also, peptide concentration had a very strong influence on peptide self-organization process. Oligomers gradually increased their size at lower concentration. Whereas, at higher ones, oligomers increased their complexity, forming branched structures. By CD, we observed that p31-43 self-organized in a polyproline II conformation in equilibrium with β-sheets-like structures, whose pH remained stable in the range of 3-8. In addition, these findings were supported by molecular dynamics simulation. The formation of p31-43 nanostructures with increased β-sheet structure may help to explain the molecular etiopathogenesis in the induction of proinflammatory effects and subsequent damage at the intestinal mucosa in CeD.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  celiac disease; gliadin p31-43 peptide; oligomers; secondary structure; self-assembly

Year:  2019        PMID: 31659864     DOI: 10.1111/febs.15109

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  6 in total

Review 1.  Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.

Authors:  Stefania Martucciello; Silvia Sposito; Carla Esposito; Gaetana Paolella; Ivana Caputo
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

2.  Dissecting the role of glutamine in seeding peptide aggregation.

Authors:  Exequiel E Barrera; Francesco Zonta; Sergio Pantano
Journal:  Comput Struct Biotechnol J       Date:  2021-03-13       Impact factor: 7.271

3.  Structural Perspective of Gliadin Peptides Active in Celiac Disease.

Authors:  Lucia Falcigno; Luisa Calvanese; Mariangela Conte; Merlin Nanayakkara; Maria Vittoria Barone; Gabriella D'Auria
Journal:  Int J Mol Sci       Date:  2020-12-06       Impact factor: 5.923

Review 4.  Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder.

Authors:  Margaret R Dunne; Greg Byrne; Fernando G Chirdo; Conleth Feighery
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

Review 5.  Programmed Cell Death in the Small Intestine: Implications for the Pathogenesis of Celiac Disease.

Authors:  Federico Perez; Carolina Nayme Ruera; Emanuel Miculan; Paula Carasi; Fernando Gabriel Chirdo
Journal:  Int J Mol Sci       Date:  2021-07-10       Impact factor: 5.923

Review 6.  Gliadin proteolytical resistant peptides: the interplay between structure and self-assembly in gluten-related disorders.

Authors:  Maria Georgina Herrera; Veronica Isabel Dodero
Journal:  Biophys Rev       Date:  2021-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.